Tag
Balaxi Pharmaceuticals Limited
2 articles
Balaxi Pharmaceuticals Clarifies NSE Price Movement Query
Balaxi Pharmaceuticals responded to an NSE query regarding significant recent price movement in its equity shares.
The company stated it has no material information that could explain the price or vol
Balaxi Pharmaceuticals Q2 PAT Surges 450% YoY
• Investor presentation details Q2 FY27 consolidated PAT surge of 450% YoY to ₹115.02 lakhs on revenue growth of 39.44%.
• Highlights operational commencement of Jadcherla formulation facility and add